For once, convicted Ponzi king Bernie Madoff has produced
profits that aren’t too good to be true.
The NY Post reports that a $2.2 million investment that he made in a small biotech
company years before his house of cards came crashing down in December 2008
more than doubled in value this week.
Stemline Therapeutics went public on Tuesday, selling 3.3
million shares at $10 a piece. The stock closed down 2 percent yesterday, at
$10.75, valuing Madoff’s initial $2.2 million investment at $5.5 million on
paper.
That’s good news for Madoff’s burned investors, who stand to
benefit if Irving Picard — the court-appointed trustee tasked with clawing back
money for victims — succeeds in grabbing those shares.
According to a lawsuit Picard filed against a Madoff family
fund, the Stemline shares “rightfully belong to... customers…..”
Wait...wait...there's more at http://www.nypost.com/p/news/business/biotech_ipo_balm_for_madoff_investors_GhdEaKOdggeYrhhBD7duGO
No comments:
Post a Comment